Program:
Start Year:
2022
Why did you choose Duke for your residency training?
Duke has an amazing sense of community and family that immediately made me feel like I would belong and thrive here. On top of that, Duke has everything I was looking for in a residency program: high volume, high acuity, amazing mentorship, strong subspecialty training, and an emphasis on resident research.
What excites you about the residency program at Duke Ob/Gyn?
I am most excited to work with and learn from the amazing talent at Duke — the world-class faculty who are dedicated leaders in their fields and also my incredible and passionate co-residents. I know that these are the people who help me grow and reach my fullest potential as a clinician, researcher, and human.
What are your career goals?
Most importantly, I hope to become a trustworthy, compassionate, and culturally competent provider and advocate for my patients. I am strongly considering fellowship, particularly in gynecologic oncology and hope to pursue a future career in academic medicine to further cultivate my interests in research and teaching.
Describe your research interests/goals:
Cancer genetics informing targeted therapeutics for gynecologic malignancies; immune microenvironment in gynecologic tumors; sexual and menopausal symptoms of gynecologic cancer survivors
What are your hobbies?
All things music! I play violin, piano, and guitar. I also love board games, baking, trying new restaurants, and binging TV.
Education & Training
Undergraduate school & graduation year:
Yale College, 2017
Medical school & graduation year:
Yale School of Medicine, 2022
Awards and Honors
The Parker Prize, Yale School of Medicine 2022
David and Harriet Seligson Thesis Prize, Yale School of Medicine 2022
Stacy Tessler Lindau Trainee Research Award, Scientific Network on Female Sexual Health and Cancer 2021
Publications
Patrich T, Wang Y, Elshaikh MA, Zhu S, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Taunk NK, Chino J, Russo AL, Lea JS, Lee LJ, Albuquerque KV, Hathout L. The Impact of Racial Disparities on Outcome in Patients With Stage IIIC Endometrial Carcinoma: A Pooled Data Analysis. Am J Clin Oncol. 2023 Mar 1;46(3):114-120. doi: 10.1097/COC.0000000000000975. Epub 2023 Jan 10. Erratum in: Am J Clin Oncol. 2023 Jun 1;46(6):279. PMID: 36625449.
Li JY, Tien CJ, Kassick M, Peters GW, Damast S. Implementing a simulation-based curriculum for hybrid intracavitary/interstitial brachytherapy using a new, commercially available, US/MR/CT-compatible gynecologic phantom. Brachytherapy. 2023 Mar-Apr;22(2):157-165. doi: 10.1016/j.brachy.2022.11.006. Epub 2022 Dec 15. PMID: 36528476.
Li JY, Park HS, Huang GS, Young MR, Ratner E, Santin A, Damast S. Prognostic impact of mismatch repair deficiency in high- and low-intermediate-risk, early-stage endometrial cancer following vaginal brachytherapy. Gynecol Oncol. 2021 Dec;163(3):557-562. doi: 10.1016/j.ygyno.2021.09.018. Epub 2021 Oct 1. PMID: 34602287.
Li JY, Mutlu L, Tymon-Rosario J, Khadraoui W, Nagarkatti N, Hui P, Buza N, Lu L, Schwartz P, Menderes G. Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites. Gynecol Oncol Rep. 2021 Dec 20;39:100913. doi: 10.1016/j.gore.2021.100913. PMID: 35005157.
Li JY, Arkfeld CK, Tymon-Rosario J, Webster E, Schwartz P, Damast S, Menderes G. An evaluation of prognostic factors, oncologic outcomes, and management for primary and recurrent squamous cell carcinoma of the vulva. J Gynecol Oncol. 2021 Nov 30. doi: 10.3802/jgo.2022.33.e13. Epub ahead of print. PMID: 34910394.
Yoon J, Fitzgerald H, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ, Hathout L. Does prophylactic para-aortic lymphatic irradiation improve outcomes in women with stage IIIC1 endometrial carcinoma? A multi-institutional pooled analysis. Pract Radiat Oncol. 2021 Nov 22:S1879-8500(21)00280-0. doi: 10.1016/j.prro.2021.10.002. Epub ahead of print. PMID: 34822999.
Li JY, D'Addario J, Tymon-Rosario J, Menderes G, Young MR, Johung K, Ratner E, Minkin MJ, Damast S. Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy. Am J Clin Oncol. 2021 Apr 1;44(4):143-149. doi: 10.1097/COC.0000000000000800. PMID: 33755031.
Hathout L, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer. Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1423-1431. doi: 10.1016/j.ijrobp.2021.02.055. Epub 2021 Mar 5. PMID: 33677053.
Diamond BH, Jairam V, Zuberi S, Li JY, Marquis TJ, Rutter CE, Park HS. Linear accelerator-based single-fraction stereotactic radiosurgery versus hypofractionated stereotactic radiotherapy for intact and resected brain metastases under 3 cm: A multi-institutional retrospective analysis. J Radiosurg SBRT. 2021;7(3):179-187. PMID: 33898081
Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz PE, Damast S. Stage III uterine serous carcinoma: modern trends in multimodality treatment. J Gynecol Oncol. 2020 Jul;31(4):e53. doi: 10.3802/jgo.2020.31.e53. Epub 2020 Feb 17. PMID: 32266802; PMCID: PMC7286763.
Ortega J, Li JY, Lee S, Tong D, Gu L, Li GM. Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis. Proc Natl Acad Sci U S A. 2015 May 5;112(18):5667-72. doi: 10.1073/pnas.1417711112. Epub 2015 Mar 30. PMID: 25825764; PMCID: PMC4426468.
Presentations
Li JY, Tien CJ, Kassick M, Peters G, Damast S. “Investigating the efficacy of simulation-based education for interstitial gynecologic brachytherapy using a novel US/MR/CT-compatible gynecologic phantom.” Accepted for oral presentation at the American Brachytherapy Society Annual Meeting. Denver, CO. Jun 2022.
Li JY, Park H, Huang G, Young MR, Ratner E, Santin A, Damast S. “Prognostic Impact of Mismatch Repair Deficiency in High- and Low-Intermediate Risk, Early-Stage Endometrial Cancer Following Vaginal Brachytherapy.” Accepted for oral presentation at the 63rd American Society for Radiation Oncology, Chicago, IL. Oct 2021.
Li JY, D'Addario J, Tymon-Rosario J, Menderes G, Young MR, Johung K, Ratner E, Minkin MJ, Damast S. “Benefits of a Multidisciplinary Women's Sexual Health Clinic in the Management of Sexual and Menopausal Symptoms After Pelvic Radiotherapy.” Accepted for oral presentation at 8th annual meeting of Scientific Network on Female Sexual Health and Cancer.
Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz P, Damast S. “Stage III Uterine Serous Carcinoma: Improved Outcomes in the Modern Era with Multi-Modality Treatment.” Accepted for oral presentation at 61st American Society for Radiation Oncology, Chicago, IL. Sept 2019.